BioCentury | Apr 10, 2020
Product Development

April 9 Quick Takes: BMS tops off CAR T patent win; plus approval for Braftovi plus Erbitux, Merck, BMS, Liquidia, Circassia-AZ, Bridge

...development and commercialization deal with AstraZeneca plc (LSE:AZN; NYSE:AZN) for Tudorza Pressair aclidinium bromide and Duaklir Pressair aclidinium bromide/formoterol...
...PELI1 (pellino-1) - Pellino E3 ubiquitin protein ligase 1 BioCentury Staff Bretaris Genuair, Eklira Genuair, Tudorza Genuair, Tudorza Pressair, aclidinium bromide (tudorza, LAS34273) BBT-401 LIQ861 Keytruda...
BioCentury | Jun 29, 2019
Finance

Biotech backs down in 2Q19

...tumors Circassia Pharmaceuticals plc (LSE:CIR) Licensed U.S. righs from AstraZeneca plc FDA approves Duaklir Pressair aclidinium bromide/formoterol...
BioCentury | Apr 5, 2019
Company News

FDA approves Circassia's COPD treatment, AZ gets $20M milestone

...treat chronic obstructive pulmonary disease. The agency also accepted for review an sNDA for Tudorza Pressair aclidinium bromide...
...Duaklir is a fixed-dose combination of Tudorza and long acting β agonist (LABA) formoterol. Tudorza...
...Pressair inhaler. Elizabeth S. Eaton, Staff Writer Bretaris Genuair, Eklira Genuair, Tudorza Genuair, Tudorza Pressair, aclidinium bromide (tudorza, LAS34273) Brimica Genuair, Duaklir Genuair, aclidinium bromide/formoterol...
BioCentury | Jan 17, 2019
Regulation

Products on shutdown standby

...Resubmission AstraZeneca plc (LSE:AZN; NYSE:AZN) Circassia Pharmaceuticals plc (LSE:CIR) has U.S. marketing rights Duaklir Pressair aclidinium bromide/formoterol...
...3/18/19 Priority AstraZeneca plc (LSE:AZN; NYSE:AZN) Circassia Pharmaceuticals plc (LSE:CIR) has U.S. marketing rights Tudorza Pressair aclidinium bromide...
BioCentury | Aug 17, 2018
Clinical News

FDA accepts applications for Circassia COPD products Duaklir, Tudorza

...obstructive pulmonary disease (COPD). The company also said the agency accepted an sNDA for Tudorza Pressair aclidinium bromide...
...2019. Duaklir is a fixed-dose combination of Tudorza and long acting beta agonist (LABA) formoterol. Tudorza...
...Tudorza Pressair aclidinium bromide Business: Pulmonary Jaime De Leon Bretaris Genuair, Eklira Genuair, Tudorza Genuair, Tudorza Pressair, aclidinium bromide (tudorza, LAS34273) Brimica Genuair, Duaklir Genuair, aclidinium bromide/formoterol...
BioCentury | Dec 1, 2017
Clinical News

Duaklir Genuair meets in Phase III to treat COPD

...trial in about 1,595 patients with chronic obstructive pulmonary disease (COPD) showing that Duaklir Genuair aclidinium bromide/formoterol...
...the co-primary endpoint of improving forced expiratory volume in 1 second (FEV1) from baseline vs. aclidinium bromide...
...to submit an NDA for Duaklir Genuair to treat COPD in 1H18. Patients received 400µg/12µg aclidinium bromide/formoterol...
BioCentury | Apr 28, 2017
Finance

A different animal?

...added more respiratory assets through a deal to lead promotion of AstraZeneca plc ’s Tudorza Pressair aclidinium bromide...
...to the COPD therapy. The deal also gives Circassia full U.S. rights to Duaklir Pressair aclidinium bromide/formoterol...
BioCentury | Apr 21, 2017
Clinical News

HDM-SPIRE: Ph IIb data

...NYSE:AZN, London, U.K.) for chronic obstructive pulmonary disease (COPD) drugs Tudorza Pressair aclidinium bromide and Duaklir Pressair aclidinium bromide/...
BioCentury | Apr 18, 2017
Clinical News

Circassia abandoning allergy field after Phase IIb miss

...AstraZeneca plc (LSE:AZN; NYSE:AZN) for chronic obstructive pulmonary disease drugs Tudorza Pressair aclidinium bromide and Duaklir Pressair aclidinium bromide/...
...9, 2015) . Under Circassia’s deal with AZ, the company is leading U.S. promotion of Tudorza...
...Circassia lost 1.75p to 101.25p on Tuesday. Jaime De Leon aclidinium bromide Aclidinium bromide/formoterol fumarate Bretaris Genuair Brimica Genuair Duaklir Genuair Eklira Genuair HDM-SPIRE KRP-AB1102F LAS34273 LAS40464 ToleroMune house dust mite therapy Tudorza Tudorza Genuair Tudorza Pressair AstraZeneca...
BioCentury | Mar 23, 2017
Company News

AZ, Circassia deal

...two chronic obstructive pulmonary disease therapies with Circassia. Circassia will lead promotion of AZ's Tudorza Pressair aclidinium bromide...
...Circassia will also obtain full U.S. rights to Duaklir Pressair aclidinium bromide/ formoterol fumarate. FDA approved Tudorza...
...NYSE:AZN), London, U.K. Circassia Pharmaceuticals plc (LSE:CIR), Oxford, U.K. Business: Pulmonary Jaime De Leon aclidinium bromide Aclidinium bromide/formoterol fumarate benralizumab Bretaris Genuair Brimica Genuair Duaklir Genuair Eklira Genuair KHK4563 KRP-AB1102F LAS40464 MEDI-563 Tudorza Tudorza Genuair Tudorza Pressair AstraZeneca...
Items per page:
1 - 10 of 105